Author: Ken Dropiewski

Vensana Capital Welcomes Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner

MINNEAPOLIS & WASHINGTON–(BUSINESS WIRE)–Vensana Capital, a leading medical technology-focused venture capital and growth equity investment firm, today announced the additions of Maria Berkman, MD, as Partner and Ross (Rusty) Segan, MD, as Venture Partner. Maria Berkman, MD, joins Vensana as a Partner after over a decade at Broadview Ventures, a […]

FineHeart Receives ANSM1 Authorization to Deploy Its First-In-Human Clinical Study in France

Patients with advanced heart failure will be treated with FlowMaker®, an innovative, fully implantable device for restoring cardiac output. BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from the French National Agency for the […]

TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System

DENVER–(BUSINESS WIRE)–TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our investigational immunotherapy, is excited to announce the launch of the TriNav® FLX Infusion System, the latest addition to the […]

MemorialCare Heart and Vascular Institute Completes First Successful TriClip Procedure for Tricuspid Valve Repair

LONG BEACH, Calif., June 4, 2025 /PRNewswire/ — The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center’s first transcatheter tricuspid valve replacement…

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR Systems Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR Systems

Vasa Therapeutics Announces Successful Completion of First-in-Human Study for Investigational Therapy VS-041, a Small Molecule Drug Candidate for Heart Failure with Preserved Ejection Fracture

VS-041 safe and well tolerated in healthy patients Biomarker trial in patients with HFpEF targeted to initiate in 2025 ENCINITAS, Calif. and WROCLAW, Poland, June 4, 2025 /PRNewswire/ — Vasa Therapeutics (“Vasa”), a clinical stage biopharmaceutical company developing novel therapies for…

MolecuLight to Showcase Innovative Wound Imaging Platform at the Society for Vascular Surgery Vascular Annual Meeting (VAM) 2025

PITTSBURGH, June 4, 2025 /PRNewswire/ – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM),…

FastWave Medical Announces Successful First-in-Human Procedures in Study of Sola™, Its Next-Generation Coronary Laser IVL System

Initial FIH procedures launch FastWave’s multi-center feasibility study evaluating the safety and performance of its laser-based coronary IVL platform. MINNEAPOLIS, June 3, 2025 /PRNewswire/ — FastWave Medical, a pioneering intravascular lithotripsy (IVL) startup, today announced the…